Conditions: Pulmonary Disease, Chronic Obstructive
Keywords: COPD long-acting beta agonist Emphysema Chronic Bronchitis Chronic Obstructive Pulmonary Disease (COPD) bronchodilator long acting muscarinic antagonist
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 61
Healthy volunteers: no

Brief summary:
The purpose of this study is the evaluate the safety and tolerability of repeat dosing of the combination of inhaled GSK233705 and GW642444 administered once-daily in subjects with COPD.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Placebo intervention 2: GSK233705/GW642444
Intervention descriptions: intervention 1: matching placebo intervention 2: The combination of the long-acting muscarinic antagonist GSK233705 and the long acting beta agonist GW642444 in a single inhaler.

Protocol document: